**Question:** The MOST sensitive 24 hour urinary biochemical test to suggest pheochromocytoma among the following is:

A. Vanillylmandelic acid (VMA)
B. Uric acid
C. Epinephrine
D. Normetanephrine

**Correct Answer:** D. Normetanephrine

**Core Concept:** Pheochromocytoma is a rare tumor that originates from chromaffin cells in the adrenal medulla or sympathetic ganglia, leading to excessive production of catecholamines (adrenaline, noradrenaline, and dopamine). These tumors are associated with hypertension and can cause severe cardiovascular complications. To diagnose pheochromocytoma, البولية biochemical tests are crucial, as they measure catecholamine derivatives and their precursors in the urine.

**Why the Correct Answer is Right:** Normetanephrine is a more sensitive and specific marker for pheochromocytoma compared to other options. It is a primary catecholamine, which is a precursor to metanephrine, and is less prone to post-synthetic degradation compared to metanephrine. This makes it a more reliable marker for detecting pheochromocytoma.

**Why Each Wrong Option is Incorrect:**

A. Vanillylmandelic acid (VMA): VMA is a biomarker for pheochromocytoma; however, it is also elevated in other conditions, including renal insufficiency and certain drugs. This makes it less specific than normetanephrine.

B. Uric acid: Uric acid is primarily a marker for renal function and is not specific to pheochromocytoma. It is not a recommended biomarker for diagnosing this condition.

C. Epinephrine: Epinephrine is a catecholamine, but it is not a urinary marker for pheochromocytoma. Its measurement is usually unreliable due to rapid renal elimination and low urinary concentration.

**Clinical Pearl:** A high level of VMA and normetanephrine in urine can be indicative of pheochromocytoma. However, the combination of high VMA and normetanephrine levels in urine is highly suggestive of this disease. In case of elevated VMA and low normetanephrine levels, consider alternative diagnosis, such as renal tubular dysfunction or medications. Always consider the clinical context while interpreting the biomarker results.